Erika Smith
EpiTET
Affiliations
Yale University
Technologies
Therapeutic
Indication
Autoimmune & Inflammation
Fibrosis
Metabolic Disease
Obesity
Women’s health
Additional Information
Immigrant-Led
Woman-Led
EpiTET’s novel, oral targets has the potential to revolutionize the way we treat a number of chronic inflammatory conditions including endometriosis, metabolic dysfunction (MASH), cancers, and other conditions. Our approach selectively eliminates pathogenic macrophages, the key drivers of chronic inflammation and disease micro-environment without suppressing overall immunity.
Program of
Initiated by
